2478. Recent Trials in Antibacterials
Session: Symposium: New Anti-Infective Clinical Trials that Will Change Your Practice
Saturday, October 7, 2017: 2:25 PM
Room: 11AB
Susan J. Rehm, MD, FIDSA, Infectious Disease, Cleveland Clinic, Cleveland, OH


S. J. Rehm, Amgen: Shareholder , divdend
Merck: Shareholder , divdend
Pfizer: Consultant and Shareholder , Consulting fee and divdend

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.